Correlation Between Lexaria Bioscience and Acer Therapeutics

Can any of the company-specific risk be diversified away by investing in both Lexaria Bioscience and Acer Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lexaria Bioscience and Acer Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Lexaria Bioscience Corp and Acer Therapeutics, you can compare the effects of market volatilities on Lexaria Bioscience and Acer Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lexaria Bioscience with a short position of Acer Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lexaria Bioscience and Acer Therapeutics.

Diversification Opportunities for Lexaria Bioscience and Acer Therapeutics

-0.33

Correlation Coefficient

Lexaria Bioscience  Acer Therapeutics

Very good diversification

The 3 months correlation between Lexaria and Acer is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding Lexaria Bioscience Corp and Acer Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acer Therapeutics and Lexaria Bioscience is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lexaria Bioscience Corp are associated (or correlated) with Acer Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acer Therapeutics has no effect on the direction of Lexaria Bioscience i.e., Lexaria Bioscience and Acer Therapeutics go up and down completely randomly.

Pair Corralation between Lexaria Bioscience and Acer Therapeutics

Given the investment horizon of 90 days Lexaria Bioscience Corp is expected to generate 0.92 times more return on investment than Acer Therapeutics. However, Lexaria Bioscience Corp is 1.09 times less risky than Acer Therapeutics. It trades about 0.03 of its potential returns per unit of risk. Acer Therapeutics is currently generating about -0.07 per unit of risk. If you would invest  255.00  in Lexaria Bioscience Corp on September 21, 2024 and sell it today you would lose (34.00) from holding Lexaria Bioscience Corp or give up 13.33% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	28.28%
Values	Daily Returns

Lexaria Bioscience Corp  vs.  Acer Therapeutics

Lexaria Bioscience Corp

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Lexaria Bioscience Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Acer Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Acer Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable technical and fundamental indicators, Acer Therapeutics is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.

Pair Trading with Lexaria Bioscience and Acer Therapeutics

The main advantage of trading using opposite Lexaria Bioscience and Acer Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lexaria Bioscience position performs unexpectedly, Acer Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acer Therapeutics will offset losses from the drop in Acer Therapeutics' long position.

The idea behind Lexaria Bioscience Corp and Acer Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.